Brucellosis and its different clinical forms of presentation: a report of three cases
DOI:
https://doi.org/10.32818/reccmi.a11n2a10Keywords:
brucellosis, zoonosis, favorable outcome, febrile syndromeAbstract
Brucellosis is a bacterial zoonosis transmitted through unpasteurized dairy products and contact with infected
animals. It maintains a high global burden and persists in Cuba. It presents with nonspecific symptoms such as
fever, generalized pain, and hepatosplenomegaly. Diagnosis integrates clinical assessment, serology, and molecular techniques such as PCR, which enable timely confirmation. We present three cases of brucellosis with diverse manifestations: febrile syndrome with splenomegaly, endocarditis, and neurobrucellosis. Diagnosis was confirmed by PCR, and specific treatment led to favorable outcomes without major complications in all hospitalized patients. The objective of this presentation is to describe a case series of brucellosis with varied clinical presentations.
Downloads
Metrics
References
Laine CG, Johnson VE, Scott HM, Arenas-Gamboa AM. Global estimate of human brucellosis incidence. Emerg Infect Dis. 2023; 29(9): 1789-97. doi: http://doi.org/10.3201/eid2909.230052 (último acceso ago. 2026). DOI: https://doi.org/10.3201/eid2909.230052
Pérez Ruano M, Álvarez Maqueira S, Armas Valdés Y, Rivera Cuesta M, Martí Cuní K, Hinojosa Quesada O, et al. Seroprevalence and factors associated with bovine brucellosis in Pinar del Río province, Cuba. Rev Investig Vet Peru. 2022; 33(4): e23341. doi: http://doi.org/10.15381/rivep.v33i4.23341 (último acceso ago. 2026). DOI: https://doi.org/10.15381/rivep.v33i4.23341
Qureshi KA, Parvez A, Fahmy NA, Abdel Hady BH, Kumar S, Ganguly A, et al. Brucellosis: epidemiology, pathogenesis, diagnosis and treatment—a comprehensive review. Ann Med. 2023; 55(2): 2295398. doi: http://doi.org/10.10 80/07853890.2023.2295398 (último acceso ago. 2026). DOI: https://doi.org/10.1080/07853890.2023.2295398
Sahin IH, Tarcan T, Yakici G. Laboratory-acquired Brucellosis: a case report. Exp Appl Med Sci. 2025; 6(3): 279-87. doi: http://doi.org/10.46871/ eams.1773058 (último acceso ago. 2026). DOI: https://doi.org/10.46871/eams.1773058
Varshochi M, Ravanbakhsh Ghavghani F. Demyelinating neurobrucellosis presenting with neuropsychiatric manifestations. Case Rep Med. 2026; 2026: 2210460. doi: http://doi.org/10.1155/carm/2210460 (último acceso ago. 2026). DOI: https://doi.org/10.1155/carm/2210460
Xu N, Qu C, Sai L, Wen S, Yang L, Wang S, et al. Evaluating the efficacy of serological testing of clinical specimens collected from patients with suspected brucellosis. PLoS Negl Trop Dis. 2023; 17(2): e0011131. doi: http:// doi.org/10.1371/journal.pntd.0011131 (último acceso ago. 2026). DOI: https://doi.org/10.1371/journal.pntd.0011131
Bhat SA, Guroo FA, Koul AN, Mantoo S, Siraj F, Soharwardy MY. Brucella endocarditis: a case series. Cureus. 2024; 16(12): e74969. doi: https://doi. org/10.7759/cureus.74969 (último acceso ago. 2026). DOI: https://doi.org/10.7759/cureus.74969
Alfakeeh S, Alghanem RF, Bin Obaid S, Alsuwayhib A, Al Kawabah G, Abanamy R, et al. Clinical characteristics and outcome of Brucella endocarditis: a case series. Infect Drug Resist. 2024;17: 4733–40. doi: http://doi. org/10.2147/IDR.S485537 (último acceso ago. 2026). DOI: https://doi.org/10.2147/IDR.S485537
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Marlon González Portela, Renán Hernández Núñez, Raúl de Jesús Delgado Serrano, Alain Rodríguez Hernández
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
